GHK-Cu Peptide Calculator

GHK-Cu (Copper Peptide GHK-Cu) is the copper(II) complex of the naturally occurring tripeptide glycyl-L-histidyl-L-lysine (GHK). The free tripeptide was first isolated from human plasma by Loren Pickart in 1973 during research into age-related changes in liver cell function—specifically the observation that plasma from young individuals stimulated liver cell biosynthesis whereas plasma from older individuals did not. The active fraction was identified as GHK, which exerts its biological activity almost exclusively through its high-affinity coordination of divalent copper ions (Cu2+). The resulting GHK-Cu complex has a stability constant of approximately 10^16 M^-1, making it one of the tightest peptide-metal chelates characterized in human physiology.

GHK-Cu is a small tripeptide with a molecular weight of 340.4 Da (free peptide) and approximately 403.9 Da as the copper complex. It is present in human plasma at concentrations of approximately 200 ng/ml at age 20, declining to approximately 80 ng/ml by age 60—a reduction of roughly 60% across the lifespan. This age-dependent decline correlates with reduced tissue repair capacity and forms the basis of GHK-Cu's research rationale as a potential regulator of age-related changes in gene expression. Its small size enables penetration through extracellular matrix and across dermal tissue barriers, which distinguishes it from larger regenerative peptides. Using an accurate GHK-Cu calculator ensures the correct BAC water ratio for the large vial sizes typical of copper peptide research.

Genome-Wide Activity: Resetting the Transcriptional Landscape

GHK-Cu's most striking and pharmacologically unusual property is its capacity to modulate the expression of a large fraction of the human genome. Microarray and RNA-sequencing studies have identified GHK-Cu as a modulator of over 4,000 human genes—approximately 31% of the protein-coding genome—at physiologically relevant concentrations. Critically, the direction of modulation is not random: GHK-Cu consistently upregulates genes associated with tissue maintenance, collagen synthesis, anti-inflammatory signaling, and antioxidant defense, while downregulating genes associated with inflammation, oxidative stress, cancer progression (particularly metastasis-promoting genes), and cellular senescence pathways. This bidirectional transcriptional reprogramming has been described as a partial reversal of the aged gene expression signature toward a more youthful transcriptional state.

Collagen Type I & III, Elastin, and Glycosaminoglycans

At the dermal level, GHK-Cu stimulates fibroblast synthesis of collagen type I and type III—the primary structural proteins of the extracellular matrix that decline with aging and are depleted at wound sites. Specifically, GHK-Cu activates the TGF-beta1 pathway and downstream Smad2/3 signaling, driving collagen gene transcription in dermal fibroblasts. Parallel stimulation of elastin synthesis restores tissue elasticity, while increased production of glycosaminoglycans (hyaluronic acid, dermatan sulfate, heparan sulfate) replenishes the hydrated matrix scaffold that supports collagen fiber organization. In rodent and in vitro wound models, GHK-Cu-treated cultures consistently demonstrate higher collagen density, smaller wound area, and greater mechanical strength at the repair site compared to controls.

Anti-inflammatory and Antioxidant Properties

GHK-Cu downregulates the NF-kappaB signaling pathway—the master transcriptional regulator of inflammatory cytokine production—reducing expression of IL-1beta, IL-6, TNF-alpha, and COX-2. Simultaneously, it upregulates superoxide dismutase (SOD1, SOD2) and catalase, two primary enzymatic antioxidant defenses. The copper ion within the complex is mechanistically relevant here: Cu2+ is a cofactor for Cu/Zn-SOD (superoxide dismutase 1), and GHK-Cu may serve as a bioavailable copper donor that replenishes the cofactor pool for this enzyme in copper-deficient tissue microenvironments. This dual anti-inflammatory and antioxidant activity positions GHK-Cu as a research tool for studying oxidative stress-driven tissue degeneration models.

Standard Research Vial Sizes

GHK-Cu research preparations use significantly larger vial sizes than most peptides studied at microgram-range doses. This reflects the compound's mechanism: unlike receptor agonists that trigger amplified signaling cascades from nanomolar occupancy, GHK-Cu acts as a transcriptional modulator requiring sufficient intracellular concentrations to shift gene expression patterns. Research preparations therefore operate in the milligram range.

• 20mg vials: used in pilot studies and low-dose in vitro cell culture experiments.
• 50mg vials: the most common research format; suitable for medium-duration in vivo protocols.
• 100mg vials: used for extended studies, high-throughput in vitro work, or protocols with multiple administration points.

GHK-Cu Copper Peptide Dosage Chart: Calculation Example

Note that GHK-Cu dosage is calculated in milligrams (mg), not micrograms (mcg). Use the GHK-Cu calculator above—enter the vial size in mg and your target dose in mg to obtain the correct unit draw. The formula is the same as for all peptides on this tool.

The Blue Solution: Visual Confirmation of Copper Chelation

A correctly reconstituted GHK-Cu solution will exhibit a characteristic clear blue color. This coloration is not a contaminant or degradation product—it is the expected optical signature of the Cu2+ coordination complex. The d-d electronic transitions of divalent copper ions in an octahedral or distorted-octahedral ligand field (provided by the imidazole nitrogen of histidine, the alpha-amino groups of glycine and lysine, and water molecules) absorb light in the orange-red region (~600-800 nm) and transmit blue wavelengths. The intensity of blue coloration is proportional to copper concentration and serves as a practical quality indicator.

Step-by-Step Reconstitution Protocol

1. 1Allow the GHK-Cu vial to reach room temperature for 15-20 minutes. The copper complex is stable across this temperature transition.
2. 2Disinfect the rubber stopper with a 70% isopropyl alcohol swab. Use strict sterile technique—the reactive Cu2+ ion can catalyze oxidation of contaminants introduced by poor aseptic practice.
3. 3Calculate your target BAC water volume using the GHK-Cu calculator above. Enter the vial size in mg. For a 50mg vial with a 2mg target dose, 5ml BAC water gives 20-unit draws on a standard insulin syringe.
4. 4Inject BAC water slowly along the inner vial wall. GHK-Cu dissolves readily. As the powder hydrates, watch for the development of the characteristic blue color—it should appear progressively as the copper complex forms in solution.
5. 5Gently swirl until the solution is uniformly clear blue and free of particulates. Refrigerate immediately at 2-8 degrees C. Protect from direct light.

Wound Healing and Skin Remodeling

GHK-Cu's most established research application is wound healing. In excisional wound models (rat and murine), topical and systemic GHK-Cu administration consistently accelerates re-epithelialization, reduces inflammatory infiltrate duration, and improves the tensile strength of repaired tissue compared to vehicle controls. The mechanism integrates multiple pathways: macrophage and mast cell chemotaxis to the wound site (GHK-Cu acts as a chemoattractant), fibroblast activation and collagen synthesis, angiogenesis induction via VEGF upregulation, and proteoglycan deposition for matrix scaffold formation. The net result is faster, better-organized tissue repair with reduced fibrotic scarring—a combination rarely achieved by single-mechanism agents.

Hair Follicle Research

GHK-Cu has been studied in hair follicle biology for its effects on follicle size, anagen (growth) phase duration, and follicle survival under androgenic stress. In rodent models and ex vivo human follicle cultures, GHK-Cu increases follicle size, stimulates vascular endothelial growth factor (VEGF) production in the dermal papilla, and upregulates Wnt/beta-catenin signaling—a pathway essential for follicle activation and hair shaft production. Notably, GHK-Cu has been observed to inhibit the miniaturization of follicles by downregulating transforming growth factor-beta2 (TGF-beta2), a key pro-apoptotic signal in follicle regression. These findings underpin research into GHK-Cu as a model compound for follicle-targeted intervention studies.

GHK-Cu vs BPC-157 for Skin Research

Researchers comparing GHK-Cu and BPC-157 for skin and wound healing models encounter fundamentally different mechanistic profiles. BPC-157 acts primarily through angiogenesis (VEGF/VEGFR2) and the FAK-paxillin pathway to promote cell migration and vascularization, with strong GI cytoprotection as a secondary endpoint. GHK-Cu acts primarily through gene expression modulation—upregulating the full spectrum of ECM synthesis genes while simultaneously suppressing inflammation and oxidative stress. In wound models, BPC-157 tends to produce faster initial vascularization; GHK-Cu produces better-organized collagen architecture and reduced scar formation. They are not mechanistic substitutes but rather complementary tools for studying different phases of the tissue repair cascade.

GHK-Cu's stability profile is defined primarily by the integrity of the Cu2+-peptide coordination bond. This bond is robust under physiological and mildly acidic pH (pH 4.5-8.0) but is vulnerable to disruption by strong reducing agents and competing chelators at any pH, and by strongly acidic conditions (pH below 4.0).

• Lyophilized powder at -20 degrees C: Stable for 24-36 months. The copper complex is stable in the dry state—the blue color may be faint or absent in lyophilized form but develops fully upon reconstitution.
• Lyophilized powder at 2-8 degrees C: Stable for 6-12 months. Acceptable for active research batches.
• Reconstituted solution at 2-8 degrees C: The blue solution is stable for 28-30 days. Monitor color intensity at each use—fading blue indicates copper dissociation from the peptide complex. Discard if colorless.
• pH stability range: Stable at pH 4.5-8.0. Do not reconstitute in solutions below pH 4.0. BAC water (pH approximately 5.5) is within the optimal range.
• Freeze-thaw cycles (reconstituted): Discouraged. Repeated cycles can gradually dissociate the Cu2+ coordination geometry, reducing complex stability without producing visible color change in early cycles.
• Incompatible compounds: Ascorbic acid, EDTA, dithiothreitol (DTT), beta-mercaptoethanol, and other chelating or reducing agents. These will irreversibly break the copper-peptide bond.

Why is GHK-Cu dosed in mg while other peptides are dosed in mcg?

The mg vs mcg distinction reflects the fundamental difference between GHK-Cu's mechanism and that of receptor-targeted peptides. Peptides that act as receptor agonists—BPC-157, Ipamorelin, Semaglutide—produce biological effects through signal amplification: a single receptor occupancy event triggers a G protein cascade that activates thousands of downstream effector molecules. This amplification means that nanomolar receptor occupancy (achievable with microgram doses) produces measurable physiological responses. GHK-Cu does not act through a single receptor-amplification mechanism. Its gene-modulatory effects require sufficient intracellular copper-peptide complex to interact with chromatin-remodeling machinery, transcription factor binding sites, and epigenetic regulators across thousands of gene loci simultaneously. This is a stoichiometric rather than catalytic mechanism—the peptide must be present in proportion to the biological substrate it modulates, not merely above a receptor-binding threshold. Consequently, effective concentrations in cell culture and animal models are in the low-to-mid micromolar range, translating to milligram-per-kilogram doses in vivo.

How long does the blue GHK-Cu solution remain stable in the refrigerator?

A properly reconstituted and stored GHK-Cu solution in bacteriostatic water at 2-8 degrees C will maintain its characteristic blue color and research-grade stability for 28-30 days. The benzyl alcohol preservative in BAC water prevents microbial growth throughout this window. Use the color as a proxy for copper complex integrity: vivid, uniform blue indicates intact Cu2+-GHK coordination; fading or colorless solution indicates progressive copper dissociation and should be treated as compromised. For long-duration studies requiring consistent dose preparation, prepare fresh vials every 21 days rather than relying on the full 30-day window—this provides a 9-day buffer against undetected early degradation. Time-stamp all reconstituted GHK-Cu vials and document color at each use in your research protocol.